Abnormal splicing switch of DMD's penultimate exon compromises muscle fibre maintenance in myotonic dystrophy

Nature Communications

Volumn 6, Issue , 2015, Pages

  Rau, Frédérique ^a   Lainé, Jeanne ^a   Ramanoudjame, Laetitita ^a   Ferry, Arnaud ^a   Arandel, Ludovic ^a   Delalande, Olivier ^b   Jollet, Arnaud ^a   Dingli, Florent ^c   Lee, Kuang Yung ^d,e   Peccate, Cécile ^a   Lorain, Stéphanie ^a   Kabashi, Edor ^a   Athanasopoulos, Takis ^f   Koo, Taeyoung ^f   Loew, Damarys ^c   Swanson, Maurice S ^d   Le Rumeur, Elisabeth ^b   Dickson, George ^f   Allamand, Valérie ^a   Marie, Joëlle ^a   Furling, Denis ^a   more..

^a SORBONNE UNIVERSITÉ   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c INSTITUT CURIE   (France)

^d College of Medicine   (United States)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^f UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; MUSCLEBLIND LIKE 1 PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; APO-DYSTROPHIN 1; DMD PROTEIN, HUMAN; DYSTROPHIN PROTEIN, ZEBRAFISH; MBNL1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MUSCLE PROTEIN; ZEBRAFISH PROTEIN;

ABNORMALITY; ADULT; MUSCLE; PROTEIN; RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EXON; EXON SKIPPING; GENE EXPRESSION; HUMAN; LOSS OF FUNCTION MUTATION; MUSCLE CELL; MYOTONIC DYSTROPHY; NONHUMAN; RNA SPLICING; SARCOPLASM; SKELETAL MUSCLE; ZEBRA FISH; ANIMAL; ELECTRON MICROSCOPY; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; METABOLISM; MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE CELL; TANDEM MASS SPECTROMETRY; ULTRASTRUCTURE;

DANIO RERIO; MUS;

ANIMALS; CHROMATOGRAPHY, LIQUID; DYSTROPHIN; EXONS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEOSTASIS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MEMBRANE PROTEINS; MICE; MICROSCOPY, ELECTRON; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MYOTONIC DYSTROPHY; REAL-TIME POLYMERASE CHAIN REACTION; RNA SPLICING; RNA-BINDING PROTEINS; SARCOPLASMIC RETICULUM; TANDEM MASS SPECTROMETRY; ZEBRAFISH PROTEINS;

EID: 84930669555     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8205     Document Type: Article

References (51)

1. Brook, J. D. et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 69, 385 (1992).
2. Fu, Y. H. et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255, 1256-1258 (1992).
3. Mahadevan, M. et al. Myotonic dystrophy mutation: An unstable CTG repeat in the 3' untranslated region of the gene. Science 255, 1253-1255 (1992).
4. Kanadia, R. N. et al. A muscleblind knockout model for myotonic dystrophy. Science 302, 1978-1980 (2003).
5. Kanadia, R. N. et al. Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3. Gene Expr. Patterns 3, 459-462 (2003).
6. Kuyumcu-Martinez, N. M., Wang, G. S. & Cooper, T. A. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol. Cell 28, 68-78 (2007).
7. Mankodi, A. et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289, 1769-1773 (2000).
8. Miller, J. W. et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19, 4439-4448 (2000).
9. Philips, A. V., Timchenko, L. T. & Cooper, T. A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280, 737-741 (1998).
10. Seznec, H. et al. Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability. Hum. Mol. Genet. 9, 1185-1194 (2000).
11. Charlet, B. N. et al. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 10, 45-53 (2002).
12. Fugier, C. et al. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat. Med. 17, 720-725 (2011).
13. Savkur, R. S., Philips, A. V. & Cooper, T. A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29, 40-47 (2001).
14. Tang, Z. Z. et al. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of CaV1.1 calcium channel. Hum. Mol. Genet. 21, 1312-1324 (2012).
15. Wheeler, T. M., Lueck, J. D., Swanson, M. S., Dirksen, R. T. & Thornton, C. A. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J. Clin. Invest. 117, 3952-3957 (2007).
16. Gao, Z. & Cooper, T. A. Reexpression of pyruvate kinase M2 in type 1 myofibers correlates with altered glucose metabolism in myotonic dystrophy. Proc. Natl. Acad. Sci. U. S. A. 110, 13570-13575 (2013).
17. Nakamori, M., Kimura, T., Fujimura, H., Takahashi, M. P. & Sakoda, S. Altered mRNA splicing of dystrophin in type 1 myotonic dystrophy. Muscle Nerve 36, 251-257 (2007).
18. Nakamori, M. et al. Splicing biomarkers of disease severity in myotonic dystrophy. Ann. Neurol. 74, 862-872 (2013).
19. Gumerson, J. D. & Michele, D. E. The dystrophin-glycoprotein complex in the prevention of muscle damage. Biomed. Res. Int. 2011, 210797 (2011).
20. Johnson, E. K. et al. Identification of new dystroglycan complexes in skeletal muscle. PLoS ONE 8, e73224 (2013).
21. Hoffman, E. P., Brown, Jr. R. H. & Kunkel, L. M. Dystrophin: The protein product of the duchenne muscular dystrophy locus. Cell 51, 919-928 (1987).
22. Koenig, M. et al. Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50, 509-517 (1987).
23. Austin, R. C., Howard, P. L., D'Souza, V. N., Klamut, H. J. & Ray, P. N. Cloning and characterization of alternatively spliced isoforms of Dp71. Hum. Mol. Genet. 4, 1475-1483 (1995).
24. Austin, R. C., Morris, G. E., Howard, P. L., Klamut, H. J. & Ray, P. N. Expression and synthesis of alternatively spliced variants of Dp71 in adult human brain. Neuromuscul. Disord. 10, 187-193 (2000).
25. Feener, C. A., Koenig, M. & Kunkel, L. M. Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature 338, 509-511 (1989).
26. Crawford, G. E. et al. Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain. J. Cell Biol. 150, 1399-1410 (2000).
27. Bies, R. D. et al. Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development. Nucleic Acids Res. 20, 1725-1731 (1992).
28. Greener, M. J., Sewry, C. A., Muntoni, F. & Roberts, R. G. The 3'-untranslated region of the dystrophin gene-conservation and consequences of loss. Eur. J. Hum. Genet. 10, 413-420 (2002).
29. Laurent, F.-X. et al. New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats. Nucleic Acids Res. 40, 3159-3171 (2012).
30. Lee, K.-Y. et al. Compound loss of muscleblind-like function in myotonic dystrophy. EMBO Mol. Med. 5, 1887-1900 (2013).
31. Ward, A. J., Rimer, M., Killian, J. M., Dowling, J. J. & Cooper, T. A. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. Hum. Mol. Genet. 19, 3614-3622 (2010).
32. Jin, H. et al. The dystrotelin, dystrophin and dystrobrevin superfamily: New paralogues and old isoforms. BMC Genomics 8, 19 (2007).
33. Bassett, D. I. et al. Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo. Dev. Camb. Engl. 130, 5851-5860 (2003).
34. Berger, J., Berger, S., Hall, T. E., Lieschke, G. J. & Currie, P. D. Dystrophindeficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology. Neuromuscul. Disord. 20, 826-832 (2010).
35. Athanasopoulos, T., Graham, I. R., Foster, H. & Dickson, G. Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD). Gene Ther. 11(Suppl 1): S109-S121 (2004).
36. Athanasopoulos, T., Foster, H., Foster, K. & Dickson, G. Codon optimization of the microdystrophin gene for Duchene muscular dystrophy gene therapy. Methods Mol. Biol. 709, 21-37 (2011).
37. Foster, H. et al. Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transfer. Mol. Ther. J. Am. Soc. Gene Ther. 16, 1825-1832 (2008).
38. Gregorevic, P. et al. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat. Med. 12, 787-789 (2006).
39. Koo, T. et al. Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of a1-syntrophin and a-dystrobrevin in skeletal muscles of mdx mice. Hum. Gene Ther. 22, 1379-1388 (2011).
40. Koo, T. et al. Long-term functional adeno-associated virus-microdystrophin expression in the dystrophic CXMDj dog. J. Gene Med. 13, 497-506 (2011).
41. Lai, Y. et al. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J. Clin. Invest. 119, 624-635 (2009).
42. Suzuki, A., Yoshida, M. & Ozawa, E. Mammalian alpha 1-and beta 1-syntrophin bind to the alternative splice-prone region of the dystrophin COOH terminus. J. Cell Biol. 128, 373-381 (1995).
43. Sadoulet-Puccio, H. M., Rajala, M. & Kunkel, L. M. Dystrobrevin and dystrophin: An interaction through coiled-coil motifs. Proc. Natl Acad. Sci. USA 94, 12413-12418 (1997).
44. Roberts, R. G. & Bobrow, M. Dystrophins in vertebrates and invertebrates. Hum. Mol. Genet. 7, 589-595 (1998).
45. Brooke, M. H. & Engel, W. K. The histographic analysis of human muscle biopsies with regard to fiber types. 3. Myotonias, myasthenia gravis, and hypokalemic periodic paralysis. Neurology 19, 469-477 (1969).
46. Harper, P. S. Myotonic Dystrophy (W.B. Saunders, 2001).
47. Schroder, J. M. & Adams, R. D. The ultrastructural morphology of the muscle fiber in myotonic dystrophy. Acta Neuropathol. 10, 218-241 (1968).
48. Thévenet, P. et al. PEP-FOLD: An updated De novo structure prediction server for both linear and disulfide bonded cyclic peptides. Nucleic Acids Res. 40, W288-W293 (2012).
49. Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc. Natl Acad. Sci. USA 98, 10037-10041 (2001).
50. Pyrkov, T. V., Chugunov, A. O., Krylov, N. A., Nolde, D. E. & Efremov, R. G. PLATINUM: A web tool for analysis of hydrophobic/hydrophilic organization of biomolecular complexes. Bioinformatics 25, 1201-1202 (2009).
51. Furling, D. et al. Defective satellite cells in congenital myotonic dystrophy. Hum. Mol. Genet. 10, 2079-2087 (2001).